|
MFSD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.54778445405191E-13 |
| Normal-vs-Stage2 |
1.81739999716157E-08 |
| Normal-vs-Stage3 |
1.04359965114043E-10 |
| Normal-vs-Stage4 |
5.84210457788004E-11 |
| Stage1-vs-Stage2 |
6.401000E-01 |
| Stage1-vs-Stage3 |
4.033800E-01 |
| Stage1-vs-Stage4 |
7.850300E-02 |
| Stage2-vs-Stage3 |
8.902200E-01 |
| Stage2-vs-Stage4 |
3.406000E-01 |
| Stage3-vs-Stage4 |
3.529400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35336186701807E-13 |
| Normal-vs-AfricanAmerican |
4.31409999945842E-07 |
| Normal-vs-Asian |
5.56729995437877E-09 |
| Caucasian-vs-AfricanAmerican |
9.043800E-01 |
| Caucasian-vs-Asian |
9.873400E-01 |
| AfricanAmerican-vs-Asian |
8.965200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.48130463029884E-14 |
| Normal-vs-Female |
1.99251726229477E-12 |
| Male-vs-Female |
6.081700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.10089715121831E-11 |
| Normal-vs-Age(41-60Yrs) |
2.16604512104368E-13 |
| Normal-vs-Age(61-80Yrs) |
2.55449994490675E-10 |
| Normal-vs-Age(81-100Yrs) |
2.381400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.462600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.012000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.807600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.995800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.033000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.458200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.572800E-01 |
| Classical-VS-Follicular |
4.838000E-02 |
| Classical-VS-Other |
3.390200E-02 |
| Classical-VS-Normal |
2.30204744156026E-12 |
| Tall-VS-Follicular |
5.659400E-01 |
| Tall-VS-Other |
1.484630E-01 |
| Tall-VS-Normal |
3.48200000055421E-07 |
| Follicular-VS-Other |
2.764600E-01 |
| Follicular-VS-Normal |
6.51819709318602E-11 |
| Other-VS-Normal |
1.83840999999907E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31850086404484E-12 |
| Normal-vs-N1 |
7.54241114009346E-12 |
| N0-vs-N1 |
5.063800E-02 |
|
|
